Health

Option Care Health’s (OPCH) “Outperform” Rating Reiterated at Barrington Research

Option Care Health’s (OPCH) “Outperform” Rating Reiterated at Barrington Research

Option Care Health (NASDAQ:OPCH – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Barrington Research in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $38.00 target price on the stock. Barrington Research’s price target points to a potential upside of 38.18% from the company’s previous close.
A number of other equities research analysts also recently issued reports on OPCH. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $35.75.
Get Option Care Health alerts:
Get Our Latest Report on OPCH
Option Care Health Trading Down 0.7%
Shares of Option Care Health stock opened at $27.50 on Tuesday. The company has a market capitalization of $4.46 billion, a price-to-earnings ratio of 22.00, a PEG ratio of 1.68 and a beta of 0.82. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. Option Care Health has a 12-month low of $21.39 and a 12-month high of $35.53. The firm’s 50-day moving average price is $28.68 and its two-hundred day moving average price is $31.12.
Option Care Health (NASDAQ:OPCH – Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, analysts forecast that Option Care Health will post 1.22 earnings per share for the current fiscal year.
Insider Transactions at Option Care Health
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was acquired at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the acquisition, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy P. Sullivan acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the acquisition, the director owned 49,229 shares in the company, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 59,411 shares of company stock valued at $1,627,576. 0.64% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in OPCH. Tidal Investments LLC bought a new position in Option Care Health in the 4th quarter valued at approximately $879,000. Two Sigma Investments LP raised its holdings in Option Care Health by 1,101.1% in the 4th quarter. Two Sigma Investments LP now owns 108,067 shares of the company’s stock valued at $2,507,000 after buying an additional 99,070 shares during the last quarter. Squarepoint Ops LLC bought a new position in Option Care Health in the 4th quarter valued at approximately $280,000. Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after buying an additional 332 shares during the last quarter. Finally, Mackenzie Financial Corp raised its holdings in Option Care Health by 1.1% in the 4th quarter. Mackenzie Financial Corp now owns 49,579 shares of the company’s stock valued at $1,150,000 after buying an additional 556 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.
Option Care Health Company Profile
(Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Five stocks we like better than Option Care Health
How to Find Undervalued Stocks
Cybersecurity Market Set to Double: This ETF Offers Exposure
What Are Dividend Champions? How to Invest in the Champions
Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
How to start investing in penny stocks
Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming